Ionis Pharmaceuticals Inc
LSE:0JDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Ionis Pharmaceuticals Inc (0JDI) under the Base Case is USD per share.
Compared with the current market price of 39.69 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 11 months.
Create a free account · No card needed
Fundamental Analysis
What Ionis Pharmaceuticals Does
Ionis Pharmaceuticals is a drug company that makes medicines based on antisense technology, a way to turn off harmful proteins by targeting RNA before they are made. It spends most of its effort on discovering and developing treatments for serious diseases, especially rare genetic, neurological, cardiovascular, and metabolic conditions. Its pipeline is the main business asset: it creates drug candidates and then tests them through clinical development.
- Headquarters
- United States of America US
- Employees
- 1 402
- IPO date
- May 17, 1991
Ionis Pharmaceuticals has a narrow economic moat
Patents on Ionis’s medicines and the chemical designs behind them make it harder for rivals to copy some of its treatments. But other companies can compete with different medicines, so this protection is limited to particular products and designs.
Read the full moat analysis
Revenue & Expenses Breakdown
Ionis Pharmaceuticals Inc
Earnings Waterfall
Ionis Pharmaceuticals Inc
What is the Intrinsic Value of one 0JDI stock?
The intrinsic value for Ionis Pharmaceuticals Inc (0JDI) under the Base Case is USD.
Is 0JDI stock undervalued or overvalued?
Compared with the current market price of 39.69 USD, the stock appears .
